Doja Cat Slammed by Fans After Wearing Shirt With Image of Alt ... - Yahoo Canada Finance

RAFA Stock  USD 0.06  0.01  8.96%   
About 62% of Rafarma Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Rafarma Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Rafarma Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Rafarma Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Doja Cat Slammed by Fans After Wearing Shirt With Image of Alt ... Yahoo Canada Finance

Read at news.google.com
Google News at Macroaxis
  

Rafarma Pharmaceuticals Fundamental Analysis

We analyze Rafarma Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rafarma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rafarma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Rafarma Pharmaceuticals is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Peers

Trending Equities

BBY  2.05   
0%
52.0%
INTC  0.69   
0%
17.0%
C  0.61   
0%
15.0%
UPS  0.17   
0%
4.0%
AAPL  0.07   
0%
1.0%
TGT  0.01   
0%
1.0%
WFC  0.00   
0%
0%
IBM  0.00   
0%
0%
S  0.00   
0%
0%
CVS  0.00   
0%
0%
MET  0.52   
13.0%
0%
HD  0.92   
23.0%
0%
AA  1.26   
32.0%
0%
AAL  1.86   
47.0%
0%
CVX  2.79   
71.0%
0%
T  3.89   
100.0%
0%

Complementary Tools for Rafarma Pink Sheet analysis

When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume